Lux Capital Management LLC 13D and 13G filings for Recursion Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:05 pm Sale | 2022-12-31 | 13G | Recursion Pharmaceuticals, Inc. RXRX | Lux Capital Management LLC | 6,004,722 3.300% | -7,016,797 (-53.89%) | Filing |
| 2022-02-14 4:16 pm Purchase | 2021-12-31 | 13G | Recursion Pharmaceuticals, Inc. RXRX | Lux Capital Management LLC | 13,021,519 8.200% | 13,021,519 (New Position) | Filing |